Related references
Note: Only part of the references are listed.Cysteamine therapy: a treatment for cystinosis, not a cure
Stephanie Cherqui
KIDNEY INTERNATIONAL (2012)
CYTE-I-HD: Phase I dose finding and tolerability study of cysteamine (cystagon) in Huntington's disease
R Dubinsky et al.
MOVEMENT DISORDERS (2006)
Cystamine treatment is neuroprotective in the YAC128 mouse model of Huntington disease
JM Van Raamsdonk et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Cerebral PET imaging and histological evidence of transglutaminase inhibitor cystamine induced neuroprotection in transgenic R6/2 mouse model of Huntington's disease
XK Wang et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2005)
Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine
MV Karpuj et al.
NATURE MEDICINE (2002)
Share Paper
